Outcomes of the 2-drug antiretroviral therapy (ART) regimen dolutegravir (DTG) plus lamivudine (3TC) in real-world settings are consistent with those observed in phase 3 clinical trials, confirming ...

Due to the suspension of US-funded antiretroviral deliveries, critical gaps in ARV availability are expected as early as Q2 2025 for patients in ABC/3TC regimen. Abacavir/Lamivudine 600/300 mg ...

21 OF THE FORMULAS TESTED HAD LITTLE TO NO DETECTABLE HEAVY METALS, INCLUDING ENFAMIL, GENTLE E’S, SIMILAC ADVANCE, AND KIRKLAND SIGNATURE PRO CARE FROM COSTCO. BUT THERE WERE ALSO SOME ...